Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
US6924313B1 · kind B1 · utility
9Cited by
40References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 23, 2002 |
| Grant date | Aug 2, 2005 |
| Priority date | — |
| Expiry date | Jun 14, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/137
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to substituted tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid trans: protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.